TREATMENT OF EXPERIMENTAL HERPES-SIMPLEX VIRUS ENCEPHALITIS WITH (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN MICE

被引：31
|
作者：
DECLERCQ, E [1 ]
ZHANG, ZX [1 ]
机构：
[1] GD SEARLE & CO LTD, SEARLE RES & DEV, HIGH WYCOMBE HP12 4HL, BUCKS, ENGLAND
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1982年 / 22卷 / 03期
关键词：
D O I：
10.1128/AAC.22.3.421
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：421 / 425
页数：5
相关论文
共 50 条
  • [31] EFFECTS OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE ON THE PROLIFERATION OF HERPES-SIMPLEX VIRUS TYPE-1-TRANSFORMED AND THYMIDINE KINASE-DEFICIENT MOUSE CELLS
    BUBLEY, G
    CRUMPACKER, C
    DECLERCQ, E
    SCHNIPPER, L
    VIROLOGY, 1983, 129 (02) : 490 - 492
  • [32] ACTIVATION OF LATENT HERPES-SIMPLEX VIRUS TYPE-2 INFECTION INVITRO REQUIRES A (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE-SENSITIVE GENE-FUNCTION
    SCHECK, AC
    WIGDAHL, B
    RAPP, F
    INTERVIROLOGY, 1987, 27 (03) : 121 - 129
  • [33] DIFFERENTIAL-EFFECTS OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE ON INFECTIONS WITH HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 IN HAIRLESS MICE
    DECLERCQ, E
    ZHANG, ZX
    JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (01): : 130 - 130
  • [34] GENOTOXIC PROPERTIES OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE (BVDU)
    OSHIRO, Y
    PIPER, CE
    SOELTER, SG
    BALWIERZ, PS
    GARRIOTT, ML
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1992, 18 (04): : 491 - 498
  • [35] MICROBIOLOGICAL SYNTHESIS OF 5-ETHYL-2'-DEOXYURIDINE AND (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
    KALINICHENKO, EN
    BARAI, VN
    BOKUT, SB
    ROMANOVA, VV
    ZINCHENKO, AI
    HERRMANN, G
    MIKHAILOPULO, IA
    BIOTECHNOLOGY LETTERS, 1989, 11 (09) : 621 - 626
  • [36] PHARMACOKINETICS OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN MICE
    DECLERCQ, E
    DESCAMPS, J
    DESOMER, P
    BARR, PJ
    JONES, AS
    WALKER, RT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (02) : 234 - 236
  • [37] (E)-5-(2-Bromovinyl)-2′-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase–expressing cells
    Wolfgang Hamel
    Dorothea Zirkel
    H. Maximilian Mehdorn
    Manfred Westphal
    Mark A Israel
    Cancer Gene Therapy, 2001, 8 : 388 - 396
  • [38] DIFFERENTIAL BINDING AFFINITIES OF SUGAR-MODIFIED DERIVATIVES OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE FOR HERPES-SIMPLEX VIRUS-INDUCED AND HUMAN CELLULAR DEOXYTHYMIDINE KINASES
    ZOU, FC
    DUTSCHMAN, GE
    DECLERCQ, E
    CHENG, YC
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (11) : 1797 - 1800
  • [39] THE RELATIONSHIP BETWEEN INCORPORATION OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE INTO HERPES-SIMPLEX VIRUS TYPE-1 DNA WITH VIRUS INFECTIVITY AND DNA INTEGRITY
    MANCINI, WR
    DECLERCQ, E
    PRUSOFF, WH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (02) : 792 - 795
  • [40] ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE TREATMENT OF SEVERE HERPES-ZOSTER IN CANCER-PATIENTS
    WILDIERS, J
    DECLERCQ, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (04): : 471 - 476
12345